The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension
SAPH
1 other identifier
interventional
72
1 country
1
Brief Summary
This randomized controlled trial examines the effects of nurse-led self-acupressure at HT7, LI4, PC6, and EX3 points on blood pressure, stress, and well-being in adults with primary hypertension. Participants are randomized to real acupressure, sham acupressure, or usual care groups for 2 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2026
CompletedFirst Posted
Study publicly available on registry
May 11, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
October 1, 2026
May 14, 2026
May 1, 2026
3 months
May 5, 2026
May 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in blood pressure
change from baseline in systolic and diastolic blood pressure measured using an automated office blood pressure monitor at 2 weeks
baseline and week 2
Secondary Outcomes (2)
change in perceived stress
baseline, week 2
change in mental well-being
baseline, week 2
Study Arms (3)
Real Acupressure Group
EXPERIMENTALparticipants receive acupressure on bilateral HT7,LI4,PC6 EX3 points. pressure applied for 15 seconds per point, 3 days per week, for 2 weeks
sham/placebo
SHAM COMPARATORParticipants receive sham acupressure on non-acupoints located 1-1.5 cm away from HT7, LI4 , PC6, and EX3 points. Pressure applied for 15 seconds per site, 3 days per week, for 2 weeks to maintain participant blinding
control
ACTIVE COMPARATORParticipants receive usual care for hypertension including prescribed antihypertensive medications and routine clinical nursing follow-up for 2 weeks. No acupressure intervention applied.
Interventions
Acupressure applied to HT7 (Shenmen), LI4 (Hegu), PC6 (Neiguan) bilaterally, and EX3 (Yintang). Pressure applied for 15 seconds per point, 3 days per week for 2 weeks by trained researcher. Total session duration approximately 1 minute.
light pressure applied to non-acupoint sites 1-1.5 cm from HT7İLI4,PC6 and EX3 points for 15 seconds per site,3 days per week for 2 weeks
Standard hypertension management including prescribed antihypertensive medication and routine clinical nursing follow-up for 2 weeks. No acupressure applied.
Eligibility Criteria
You may qualify if:
- Aged 18-65 years
- Diagnosed with primary hypertension (Stage 1 or 2)
- Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg
- Taking antihypertensive medication
- Able to understand and communicate in Turkish
- Willing to provide written informed consent
You may not qualify if:
- Secondary hypertension
- Pregnancy or lactation
- Severe cardiovascular disease (heart failure, myocardial infarction within 6 months)
- Stroke history within 6 months
- Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3)
- Peripheral neuropathy affecting sensation
- Current use of anticoagulant therapy
- Participation in another clinical trial within 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
A Family Health Center in Duzce
Düzce, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saadet Can Cicek, Associate Professor,PhD
Abant Izzet Baysal University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.Saadet Can Cicek,Phd
Study Record Dates
First Submitted
May 5, 2026
First Posted
May 11, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 14, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect participant confidentiality as stated in the informed consent form approved by the ethics committee. Data will only be accessible to the study team for the purposes of this study.